NCT07068932View on ClinicalTrials.gov

A Clinical Study of SHR-4506 Injection in Patients With Malignant Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

July 22, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

August 31, 2027

Conditions
Malignant Tumors of Adults
Interventions
DRUG

SHR-4506 Injection

SHR-4506 injection.

Trial Locations (2)

200025

RECRUITING

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

200127

RECRUITING

Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY